Efficacy and Safety of Sirolimus-Eluting Stent With Biodegradable Polymer Ultimaster™ in Unselected Korean Population: A Multicenter, Prospective, Observational Study From Korean Multicenter Ultimaster Registry
Korean Circulation Journal · 2024 · 54 (6) · 339
DOI: 10.4070/kcj.2024.0023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Korean Circulation Journal, 2024. Verfasst von Soohyung Park und 19 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Terumo Korea Co., Ltd.
Abstract (Originalsprache)
BACKGROUND AND OBJECTIVES: Ultimaster™, a third-generation sirolimus-eluting stent using biodegradable polymer, has been introduced to overcome long term adverse vascular events, such as restenosis or stent thrombosis. In the present study, we aimed to evaluate the 12-month clinical outcomes of Ultimaster™ stents in Korean patients with coronary artery disease. METHODS: This study is a multicenter, prospective, observational registry across 12 hospitals. To reflect real-world clinical evidence, non-selective subtypes of patients and lesions were included in this study. The study end point was target lesion failure (TLF) (the composite of cardiac death, target vessel myocardial infarction [MI], and target lesion revascularization [TLR]) at 12-month clinical follow up. RESULTS: A total of 576 patients were enrolled between November 2016 and May 2021. Most of the patients were male (76.5%), with a mean age of 66.0±11.2 years. Among the included patients, 40.1% had diabetes mellitus (DM) and 67.9% had acute coronary syndrome (ACS). At 12 months, the incidence of TLF was 4.1%. The incidence of cardiac death was 1.5%, MI was 1.0%, TLR was 2.7%, and stent thrombosis was 0.6%. In subgroup analysis based on the presence of ACS, DM, hypertension, dyslipidemia, or bifurcation, there were no major differences in the incidence of the primary endpoint. CONCLUSIONS: The present registry shows that Ultimaster™ stent is safe and effective for routine real-world clinical practice in non-selective Korean patients, having a low rate of adverse events at least up to 12 months.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
- Cardiovascular Research Institute, Korea University, Seoul, Korea. swrha617@yahoo.co.kr.
- Cardiovascular Research Institute, Korea University, Seoul, Korea.
- Division of Cardiology, Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Korea.
- Division of Cardiology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea.
- Division of Cardiology, Department of Internal Medicine, Inha University College of Medicine, Incheon, Korea.
ORCID-Profile: Soohyung Park, Seung-Woon Rha, Byoung Geol Choi, Jae-Bin Seo, Ik Jun Choi, Sung-Il Woo, Soo-Han Kim, Tae Hoon Ahn, Jae Sang Kim, Ae-Young Her, Ji-Hun Ahn, Han Cheol Lee, Jaewoong Choi, Jin Soo Byon, Markz Rmp Sinurat, Se Yeon Choi, Jinah Cha, Su Jin Hyun, Cheol Ung Choi, Chang Gyu Park
Förderung
- Terumo Korea Co., Ltd
Zitieren
APA
Park, S., Rha, S. W., Choi, B. G., Seo, J. B., Choi, I. J., Woo, S. I., Kim, S. H., Ahn, T. H., Kim, J. S., Her, A. Y., Ahn, J. H., Lee, H. C., Choi, J., Byon, J. S., Sinurat, M. R., Choi, S. Y., Cha, J., Hyun, S. J., Choi, C. U., & Park, C. G. (2024). Efficacy and Safety of Sirolimus-Eluting Stent With Biodegradable Polymer Ultimaster™ in Unselected Korean Population: A Multicenter, Prospective, Observational Study From Korean Multicenter Ultimaster Registry. Korean Circulation Journal, 54(6), 339. https://doi.org/10.4070/kcj.2024.0023
Vancouver
Park S, Rha SW, Choi BG, Seo JB, Choi IJ, Woo SI, et al. Efficacy and Safety of Sirolimus-Eluting Stent With Biodegradable Polymer Ultimaster™ in Unselected Korean Population: A Multicenter, Prospective, Observational Study From Korean Multicenter Ultimaster Registry. Korean Circulation Journal. 2024;54(6):339. doi:10.4070/kcj.2024.0023
BibTeX
@article{Park2024,
author = {Park, Soohyung and Rha, Seung-Woon and Choi, Byoung Geol and Seo, Jae-Bin and Choi, Ik Jun and Woo, Sung-Il and Kim, Soo-Han and Ahn, Tae Hoon and Kim, Jae Sang and Her, Ae-Young and Ahn, Ji-Hun and Lee, Han Cheol and Choi, Jaewoong and Byon, Jin Soo and Sinurat, Markz Rmp and Choi, Se Yeon and Cha, Jinah and Hyun, Su Jin and Choi, Cheol Ung and Park, Chang Gyu},
title = {Efficacy and Safety of Sirolimus-Eluting Stent With Biodegradable Polymer Ultimaster™ in Unselected Korean Population: A Multicenter, Prospective, Observational Study From Korean Multicenter Ultimaster Registry},
journal = {Korean Circulation Journal},
year = {2024},
volume = {54},
number = {6},
pages = {339},
doi = {10.4070/kcj.2024.0023}
}
EUVIMED